Paul Isherwood
Director, Patient and Site Engagement
Paul brings more than 15 years of experience in patient recruitment, engagement, and insights-driven trial strategy to his role at Worldwide Clinical Trials. As Director of Patient & Site Engagement, Paul works to advance a more insights-driven approach to clinical research by integrating perspectives from both investigator sites and patients. He helps to shape trials that are more patient-centered and operationally feasible. Since joining Worldwide, Paul has expanded his remit to include the Site Alliance team, deepening the organization’s ability to draw on two complementary sources of expertise. He believes that investigator sites provide invaluable operational knowledge in translating protocols into real-world practice across diverse countries and healthcare systems, while patient insights offer a critical understanding of disease experience, motivations, barriers, and participation challenges. Together, these perspectives inform study designs that work.
Ask Paul a question
Submit an RFP. Ask a Question
Prior to joining Worldwide, Paul spent more than a decade at Parexel, where he held progressively senior roles spanning recruitment operations, business development, and strategic patient engagement. He initially served as a Patient Recruitment Lead supporting active study delivery before moving into business development, where he combined his recruitment expertise with a strong focus on patient integration. He later led the Patient Insights and Strategy team, partnering with sponsors to develop solutions that embedded the patient voice into the study design and execution from the earliest stages.
Paul began his career at a large CRO’s Phase I unit in central Manchester, U.K., specializing in First-in-Human and Phase I clinical trial recruitment. His early work focused on volunteer and patient outreach, management of in-house participants databases, and the development of recruitment marketing materials. He subsequently led recruitment operations across Manchester and London within a Phase II and III viral challenge setting, where he developed and executed patient recruitment strategies, managed marketing budgets and drove enrolment performance across multiple concurrent studies.
